Giant serous papillary cystadenoma.
作者信息
Dey Madhusudan, Pathak Niloy
机构信息
Graded Specialist (Obst and Gynae), 164 MH, C/o 99 APO.
Graded Specialist (Pathology), MH, Agra.
出版信息
Med J Armed Forces India. 2011 Jul;67(3):272-3. doi: 10.1016/S0377-1237(11)60059-2. Epub 2011 Aug 7.
Abstract
摘要
相似文献
1
Giant serous papillary cystadenoma.巨大浆液性乳头状囊腺瘤
Med J Armed Forces India. 2011 Jul;67(3):272-3. doi: 10.1016/S0377-1237(11)60059-2. Epub 2011 Aug 7.
2
Serous cystadenoma of the pancreas with papillary features: a diagnostic pitfall on fine-needle aspiration biopsy.具有乳头状特征的胰腺浆液性囊腺瘤：细针穿刺活检中的诊断陷阱。
Arch Pathol Lab Med. 2001 Dec;125(12):1591-4. doi: 10.5858/2001-125-1591-SCOTPW.
3
Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor.胰腺大囊性腺瘤：浆液性寡囊性腺瘤与黏液性囊腺瘤及导管内乳头状黏液性肿瘤的CT鉴别诊断
AJR Am J Roentgenol. 2006 Nov;187(5):1192-8. doi: 10.2214/AJR.05.0337.
4
SEROUS PAPILLARY CYSTADENOMA ARISING IN PARAMESONEPHRIC REST OF THE MESOSALPINX.中输卵管副中肾残余发生的浆液性乳头状囊腺瘤。
Obstet Gynecol. 1963 Nov;22:684-7.
5
Macrocystic serous cystadenoma mimicking branch duct intraductal papillary mucinous neoplasm.酷似分支导管内乳头状黏液性肿瘤的大囊型浆液性囊腺瘤
Int Surg. 2009 Apr-Jun;94(2):176-81.
6
[SEROUS CYSTADENOMA OF THE OVARY].
Rev Bras Cir. 1964 Mar;47:145-52.
7
Leiomyosarcoma arising in serous cystadenoma of ovary: report of a case.
Ann Chir Gynaecol Fenn. 1960;49:240-4.
8
SEROUS PAPILLARY OVARIAN TUMOURS. A STUDY OF 233 CASES WITH SPECIAL REFERENCE TO THE HISTOLOGICAL TYPE OF TUMOUR AND ITS INFLUENCE IN PROGNOSIS.
Acta Obstet Gynecol Scand. 1963;42(S3):7-77. doi: 10.3109/00016346309158167.
9
ESTROGENIC ACTIVITY OF THE SEROUS CYSTADENOMA OF THE OVARY.卵巢浆液性囊腺瘤的雌激素活性
Cancer. 1965 Aug;18:1041-7. doi: 10.1002/1097-0142(196508)18:8<1041::aid-cncr2820180816>3.0.co;2-i.
10
引用本文的文献
1
Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking.新辅助化疗在卵巢浆液性癌减瘤手术中的作用
Cureus. 2022 Sep 7;14(9):e28909. doi: 10.7759/cureus.28909. eCollection 2022 Sep.
2
[Huge ovarian tumor in a perimenopausal woman: a case report].[围绝经期女性的巨大卵巢肿瘤：一例报告]
Pan Afr Med J. 2021 Mar 2;38:232. doi: 10.11604/pamj.2021.38.232.28240. eCollection 2021.
3
A Postmenopausal Woman with Giant Ovarian Serous Cyst Adenoma: A Case Report with Brief Literature Review.一名患有巨大卵巢浆液性囊腺瘤的绝经后女性：病例报告及简要文献综述
Case Rep Obstet Gynecol. 2018 Apr 4;2018:5478328. doi: 10.1155/2018/5478328. eCollection 2018.
本文引用的文献
1
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.可溶性表皮生长因子受体（sEGFR）[校正后]和癌抗原125（CA125）作为上皮性卵巢癌的筛查和诊断检测。
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):306-18. doi: 10.1158/1055-9965.EPI-04-0423.
2
The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.一组肿瘤标志物（CA 125、CA 15 - 3和CA 72 - 4抗原）在盆腔肿块患者中的鉴别诊断潜力。
Am J Obstet Gynecol. 2002 Aug;187(2):385-92. doi: 10.1067/mob.2002.123768.
3
The characterization of common ovarian cysts in premenopausal women.绝经前女性常见卵巢囊肿的特征
Ultrasound Obstet Gynecol. 2001 Feb;17(2):140-4. doi: 10.1046/j.1469-0705.2001.00330.x.
4
The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals.用于评估当地医院潜在卵巢癌的恶性风险指数。
Obstet Gynecol. 1999 Mar;93(3):448-52.
5
Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.通过检测CA 125和超声检查对绝经后妇女进行卵巢癌患病率筛查。
BMJ. 1993 Apr 17;306(6884):1030-4. doi: 10.1136/bmj.306.6884.1030.
6
Peritoneal epithelial lesions associated with proliferative serous tumours of ovary.与卵巢浆液性增殖性肿瘤相关的腹膜上皮病变
Histopathology. 1984 Mar;8(2):195-208. doi: 10.1111/j.1365-2559.1984.tb02336.x.
Zotero 插件